Home // Events // Use of a Prescription Janus Kinase (JAK) Inhibitor for Active Ankylosing Spondylitis (AS), Including Review of a Hypothetical Patient Case
Use of a Prescription Janus Kinase (JAK) Inhibitor for Active Ankylosing Spondylitis (AS), Including Review of a Hypothetical Patient Case
